Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
NCT Number: NCT02690532
This study will assess the effect of gluten on gut barrier function. Investigators at the Mayo Clinic have developed a new gut permeability test using rhamnose (sugar & water solution), and are hoping to prove its effectiveness in a clinical setting.
Looking for future studies?
Notify Me2 year–17 year
All sexes
Observational
Rochester, Minnesota, 55905, United States
The aim of this study is to assess effect of gluten on the gut barrier function in patients at high risk for celiac disease and non-celiac gluten sensitivity (NCGS) patients. This study will assess the gut permeability in three groups of patients 1) children who are at high risk for developing celiac disease (CD) (siblings of patients with celiac disease), 2) Children who are self-diagnosed with NCGS and 3) control group of patients matched for age and gender. Patients will undergo celiac serologic and genetic testing, after which the rhamnose test will be performed to assess the presence of increased gut permeability.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
High Risk group:
Non-Celiac Gluten Sensitivity group:
Healthy group:
Time frame: Baseline
Assess the effect of gluten on gut permeability in children at high risk of developing celiac disease or gluten sensitivity
Mayo Clinic
Other
The Role of Gut Permeability in Developing Celiac Disease and Non-Celiac Gluten Sensitivity
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03543540
Celiac Disease, Coeliac Disease
Herston, Queensland, Australia
View Trial DetailsNCT07366151
Celiac Disease, Digestive System Diseases
Tampere, Finland
View Trial DetailsNCT05209568
Celiac Disease, Celiac Disease in Children
Aurora, Colorado, United States
View Trial DetailsNCT06657001
Celiac Disease, Colitis
Rochester, Minnesota, United States
View Trial Details